The effect of apelin-13 on memory of scopolamine-treated rats and accumulation of amyloid-beta plaques in the hippocampus
Open Access
- 1 January 2023
- journal article
- Published by Apex Publishing in Journal of Clinical and Basic Research
- Vol. 7 (4) , 15-19
Abstract
Background: Neurodegenerative diseases (NDDs) cause progressive neuronal loss, resulting in morbidity and mortality. Research is continued on treatment strategies that can tackle the disease's pathophysiology and cease its progression. Considering the anti-apoptotic and neuroprotective properties of apelin, we hypothesized that apelin-13 could be a therapeutic solution for Alzheimer's disease and similar ...Keywords
This publication has 45 references indexed in Scilit:
- Neuroprotective Roles of Apelin-13 in Neurological DiseasesNeurochemical Research, 2023
- Apelin–13 protects against memory impairment and neuronal loss, Induced by Scopolamine in male ratsMetabolic Brain Disease, 2022
- Research Progress on Mechanism of Neuroprotective Roles of Apelin-13 in Prevention and Treatment of Alzheimer’s DiseaseNeurochemical Research, 2021
- Serum apelin‐13 levels and total oxidant/antioxidant status of patients with Alzheimer’s diseaseAging Medicine, 2021
- Trends in the public health significance, definitions of disease, and implications for prevention of Alzheimer’s diseaseCurrent Epidemiology Reports, 2020
- 2020 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2020
- Apelin/APJ system: A novel promising target for neurodegenerative diseasesJournal of Cellular Physiology, 2019
- Experimental Medicine Approaches in CNS Drug Development2019
- Molecular Mechanisms of Learning and Memory**The authors declare no competing financial interests.2016
- Bone Marrow-Derived Endothelial Progenitor Cells Protect Against Scopolamine-Induced Alzheimer-Like Pathological AberrationsMolecular Neurobiology, 2014